CANbridge Pharmaceuticals Inc.
HKEX:1228.HK
0.295 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 124.901 | 137.491 | 271.16 | 283.558 | 451.157 | 463.107 | 604.616 | 604.616 | 745.815 | 745.815 | 442.1 | 408.601 | 360.804 | 360.804 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 124.901 | 137.491 | 271.16 | 283.558 | 451.157 | 463.107 | 604.616 | 604.616 | 745.815 | 745.815 | 442.1 | 408.601 | 360.804 | 360.804 |
| Net Receivables
| 31.228 | 31.228 | 26.387 | 26.387 | 19.054 | 19.054 | 14.553 | 14.553 | 9.141 | 9.141 | 7.128 | 6.087 | 7.04 | 7.04 |
| Inventory
| 8.783 | 8.783 | 19.883 | 19.883 | 9.824 | 9.824 | 9.602 | 9.602 | 13.448 | 13.448 | 1.269 | 1.793 | 0.553 | 0.553 |
| Other Current Assets
| 32.362 | 32.362 | 12.425 | 12.425 | 13.175 | 13.175 | 25.348 | 25.348 | 43.307 | 43.307 | 29.935 | 10.71 | 22.648 | 22.648 |
| Total Current Assets
| 209.864 | 209.864 | 342.253 | 342.253 | 505.16 | 505.16 | 654.119 | 654.119 | 811.711 | 811.711 | 480.432 | 427.191 | 391.045 | 391.045 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 109.007 | 109.007 | 141.679 | 141.679 | 125.595 | 144.717 | 131.339 | 131.339 | 29.542 | 29.542 | 16.089 | 15.541 | 15.57 | 15.57 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 76.491 | 76.491 | 83.385 | 83.385 | 68.133 | 49.011 | 50.185 | 50.185 | 51.269 | 51.269 | 54.85 | 56.78 | 179.743 | 179.743 |
| Goodwill and Intangible Assets
| 76.491 | 76.491 | 83.385 | 83.385 | 68.133 | 49.011 | 50.185 | 50.185 | 51.269 | 51.269 | 54.85 | 56.78 | 179.743 | 179.743 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 1.73 | 1.73 | 3.157 | 3.157 | 6.807 | 6.807 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 185.498 | 185.498 | 226.794 | 226.794 | 196.885 | 196.885 | 188.331 | 188.331 | 80.811 | 80.811 | 70.939 | 72.321 | 195.313 | 195.313 |
| Total Assets
| 395.362 | 395.362 | 569.047 | 569.047 | 702.045 | 702.045 | 842.45 | 842.45 | 892.522 | 892.522 | 551.371 | 499.512 | 586.358 | 586.358 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 198.054 | 198.054 | 172.234 | 172.234 | 107.54 | 107.54 | 108.307 | 108.307 | 43.607 | 43.607 | 42.108 | 60.013 | 46.713 | 46.713 |
| Short Term Debt
| 34.724 | 23.69 | 36.684 | 26.873 | 39.895 | 26.867 | 35.465 | 29.904 | 38.75 | 30.868 | 19.779 | 14.001 | 27.833 | 22.314 |
| Tax Payables
| 2.477 | 0 | 0 | 0 | 1.382 | 0 | 0 | 0 | 1.477 | 0 | 1.115 | 0 | 0.995 | 0 |
| Deferred Revenue
| -11.034 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 106.201 | 106.201 | 121.557 | 131.368 | 130.67 | 143.698 | 70.873 | 76.434 | 103.423 | 111.305 | 39.038 | 44.141 | 33.557 | 39.076 |
| Total Current Liabilities
| 327.945 | 327.945 | 330.475 | 330.475 | 278.105 | 278.105 | 214.645 | 214.645 | 185.78 | 185.78 | 100.925 | 118.155 | 108.103 | 108.103 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 107.205 | 107.205 | 115.131 | 115.131 | 115.385 | 115.385 | 121 | 121 | 13.351 | 13.351 | 10.167 | 2,221.827 | 19.062 | 2,186.183 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,505.077 | 29.768 | 2,205.049 | 37.928 |
| Total Non-Current Liabilities
| 107.205 | 107.205 | 115.131 | 115.131 | 115.385 | 115.385 | 121 | 121 | 13.351 | 13.351 | 2,515.244 | 2,251.595 | 2,224.111 | 2,224.111 |
| Total Liabilities
| 435.15 | 435.15 | 445.606 | 445.606 | 393.49 | 393.49 | 335.645 | 335.645 | 199.131 | 199.131 | 2,616.169 | 2,369.75 | 2,332.214 | 2,332.214 |
| Equity: | ||||||||||||||
| Preferred Stock
| 3,789.442 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,777.244 | 0 | 2,074.384 | 0 | 1,772.225 | 0 |
| Common Stock
| 0.028 | 0.028 | 0.028 | 0.028 | 0.028 | 0.028 | 0.028 | 0.028 | 0.028 | 0.028 | 0.005 | 0.005 | 0.005 | 0.005 |
| Retained Earnings
| -3,789.442 | -3,789.442 | -3,628.766 | -3,628.766 | -3,410.605 | -3,410.605 | -3,176.142 | -3,176.142 | -2,927.13 | -2,927.13 | -2,194.327 | -1,962.487 | -1,850.124 | -1,850.124 |
| Accumulated Other Comprehensive Income/Loss
| -39.816 | 276.549 | 278.96 | 278.96 | 247.876 | 247.876 | 212.312 | 212.312 | 149.886 | 149.886 | 119.943 | 82.663 | 77.899 | 77.899 |
| Other Total Stockholders Equity
| -0 | 3,473.077 | 3,473.219 | 3,473.219 | 3,471.256 | 3,471.256 | 3,470.607 | 3,470.607 | 693.363 | 3,470.607 | -2,064.803 | 9.581 | -1,745.861 | 26.364 |
| Total Shareholders Equity
| -39.788 | -39.788 | 123.441 | 123.441 | 308.555 | 308.555 | 506.805 | 506.805 | 693.391 | 693.391 | -2,064.798 | -1,870.238 | -1,745.856 | -1,745.856 |
| Total Equity
| -39.788 | -39.788 | 123.441 | 123.441 | 308.555 | 308.555 | 506.805 | 506.805 | 693.391 | 693.391 | -2,064.798 | -1,870.238 | -1,745.856 | -1,745.856 |
| Total Liabilities & Shareholders Equity
| 395.362 | 395.362 | 569.047 | 569.047 | 702.045 | 702.045 | 842.45 | 842.45 | 892.522 | 892.522 | 551.371 | 499.512 | 586.358 | 586.358 |